Guardant Health shares are trading higher after Bernstein initiated coverage on the stock with an Outperform rating and $34 price target.
Portfolio Pulse from Benzinga Newsdesk
Bernstein initiated coverage on Guardant Health with an Outperform rating and a price target of $34, leading to a rise in the company's shares.
September 28, 2023 | 2:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guardant Health's stock is trading higher after Bernstein initiated coverage with an Outperform rating and a $34 price target.
The Outperform rating and the $34 price target set by Bernstein indicate a positive outlook for Guardant Health. This has led to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100